Valeant Pharmaceuticals to sell some assets to Nestle For $1.4 billion

Home › Valeant Pharmaceuticals to sell some assets to Nestle For $1.4 billion

Valeant Pharmaceuticals International, Inc. says it has agreed to sell the rights to five products to Nestle S.A. for $1.4 billion.

01.07	Hurricane Beryl Update Statement
01.07	Summary for Hurricane Beryl (AT2/AL022024)
01.07	BASFs TECH Academy Introduces Louisiana High School Students to Technical Careers
01.07	Comericas Patterson Helps Entrepreneurs Grow Their Waste and Recycling Businesses
01.07	Hitachi Zosen Inova Acquires Babcock & Wilcox's Denmark-Based Renewable Parts and Services Subsidiary
01.07	Hurricane Beryl Graphics
01.07	Hurricane Beryl Public Advisory Number 11A
01.07	Summary for Hurricane Beryl (AT2/AL022024)
More »

je.st